242 related articles for article (PubMed ID: 29304781)
1. Evaluation of Endoglin (CD105) expression in pediatric rhabdomyosarcoma.
Di Paolo V; Russo I; Boldrini R; Ravà L; Pezzullo M; Benedetti MC; Galardi A; Colletti M; Rota R; Orlando D; Crocoli A; Peinado H; Milano GM; Di Giannatale A
BMC Cancer; 2018 Jan; 18(1):31. PubMed ID: 29304781
[TBL] [Abstract][Full Text] [Related]
2. Prognostic angiogenic markers (endoglin, VEGF, CD31) and tumor cell proliferation (Ki67) for gastrointestinal stromal tumors.
Basilio-de-Oliveira RP; Pannain VL
World J Gastroenterol; 2015 Jun; 21(22):6924-30. PubMed ID: 26078569
[TBL] [Abstract][Full Text] [Related]
3. Endoglin (CD 105) as a potential prognostic factor in neuroblastoma.
Ćavar S; Jelašić D; Seiwerth S; Milošević M; Hutinec Z; Mišić M
Pediatr Blood Cancer; 2015 May; 62(5):770-5. PubMed ID: 25683142
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of angiogenesis in non-small cell lung cancer: comparison between anti-CD34 antibody and anti-CD105 antibody.
Tanaka F; Otake Y; Yanagihara K; Kawano Y; Miyahara R; Li M; Yamada T; Hanaoka N; Inui K; Wada H
Clin Cancer Res; 2001 Nov; 7(11):3410-5. PubMed ID: 11705856
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of microvessel density determined by an anti-CD105/endoglin monoclonal antibody in astrocytic tumors: comparison with an anti-CD31 monoclonal antibody.
Yao Y; Kubota T; Takeuchi H; Sato K
Neuropathology; 2005 Sep; 25(3):201-6. PubMed ID: 16193836
[TBL] [Abstract][Full Text] [Related]
6. Endoglin (CD105) is a useful marker for evaluating microvessel density and predicting prognosis in esophageal squamous cell carcinoma.
Sakurai T; Okumura H; Matsumoto M; Uchikado Y; Owaki T; Kita Y; Setoyama T; Omoto I; Kijima Y; Ishigami S; Natsugoe S
Anticancer Res; 2014 Jul; 34(7):3431-8. PubMed ID: 24982351
[TBL] [Abstract][Full Text] [Related]
7. Endoglin is a better marker than CD31 in evaluation of angiogenesis in glioblastoma.
Behrem S; Zarkovic K; Eskinja N; Jonjic N
Croat Med J; 2005 Jun; 46(3):417-22. PubMed ID: 15861521
[TBL] [Abstract][Full Text] [Related]
8. Independent prognostic relevance of microvessel density in advanced epithelial ovarian cancer and associations between CD31, CD105, p53 status, and angiogenic marker expression: A Gynecologic Oncology Group study.
Rubatt JM; Darcy KM; Hutson A; Bean SM; Havrilesky LJ; Grace LA; Berchuck A; Secord AA
Gynecol Oncol; 2009 Mar; 112(3):469-74. PubMed ID: 19135712
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical expression of vascular endothelial growth factor (VEGF) does not correlate with microvessel density in renal cell carcinoma.
Raica M; Cimpean AM; Anghel A
Neoplasma; 2007; 54(4):278-84. PubMed ID: 17822316
[TBL] [Abstract][Full Text] [Related]
10. Endoglin (CD 105) is expressed on endothelial cells in the primary central nervous system lymphomas and correlates with survival.
Sugita Y; Takase Y; Mori D; Tokunaga O; Nakashima A; Shigemori M
J Neurooncol; 2007 May; 82(3):249-56. PubMed ID: 17102906
[TBL] [Abstract][Full Text] [Related]
11. Neovascularity as a prognostic marker in renal cell carcinoma.
Bauman TM; Huang W; Lee MH; Abel EJ
Hum Pathol; 2016 Nov; 57():98-105. PubMed ID: 27436827
[TBL] [Abstract][Full Text] [Related]
12. Markers of angiogenesis in high-risk, early-stage cervical cancer: A Gynecologic Oncology Group study.
Randall LM; Monk BJ; Darcy KM; Tian C; Burger RA; Liao SY; Peters WA; Stock RJ; Fruehauf JP
Gynecol Oncol; 2009 Mar; 112(3):583-9. PubMed ID: 19110305
[TBL] [Abstract][Full Text] [Related]
13. Expression of endoglin (CD105) in cervical cancer.
Zijlmans HJ; Fleuren GJ; Hazelbag S; Sier CF; Dreef EJ; Kenter GG; Gorter A
Br J Cancer; 2009 May; 100(10):1617-26. PubMed ID: 19352388
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological and prognostic implications of endoglin (CD105) expression in hepatocellular carcinoma and its adjacent non-tumorous liver.
Ho JW; Poon RT; Sun CK; Xue WC; Fan ST
World J Gastroenterol; 2005 Jan; 11(2):176-81. PubMed ID: 15633211
[TBL] [Abstract][Full Text] [Related]
15. Correlation between apoptotic index and angiogenesis in non-small cell lung cancer: comparison between CD105 and CD34 as a marker of angiogenesis.
Tanaka F; Otake Y; Yanagihara K; Kawano Y; Miyahara R; Li M; Ishikawa S; Wada H
Lung Cancer; 2003 Mar; 39(3):289-96. PubMed ID: 12609567
[TBL] [Abstract][Full Text] [Related]
16. Expression of angiopoietins and its clinical significance in non-small cell lung cancer.
Tanaka F; Ishikawa S; Yanagihara K; Miyahara R; Kawano Y; Li M; Otake Y; Wada H
Cancer Res; 2002 Dec; 62(23):7124-9. PubMed ID: 12460935
[TBL] [Abstract][Full Text] [Related]
17. The prognostic value of endoglin (CD105) expression in ovarian carcinoma.
Taskiran C; Erdem O; Onan A; Arisoy O; Acar A; Vural C; Erdem M; Ataoglu O; Guner H
Int J Gynecol Cancer; 2006; 16(5):1789-93. PubMed ID: 17009973
[TBL] [Abstract][Full Text] [Related]
18. Endoglin (CD105) and vascular endothelial growth factor as prognostic markers in colorectal cancer.
Saad RS; Liu YL; Nathan G; Celebrezze J; Medich D; Silverman JF
Mod Pathol; 2004 Feb; 17(2):197-203. PubMed ID: 14657950
[TBL] [Abstract][Full Text] [Related]
19. Angiogenesis index CD105 (endoglin)/CD31 (PECAM-1) as a predictive factor for invasion and proliferation in intraductal papillary mucinous neoplasm (IPMN) of the pancreas.
Tachezy M; Reichelt U; Melenberg T; Gebauer F; Izbicki JR; Kaifi JT
Histol Histopathol; 2010 Oct; 25(10):1239-46. PubMed ID: 20712008
[TBL] [Abstract][Full Text] [Related]
20. Expression of Endoglin and Vascular Endothelial Growth Factor as Prognostic Markers in Experimental Colorectal Cancer.
Ilhan N; Gungor H; Gul HF; Eroksuz H
Anticancer Res; 2016 Aug; 36(8):3953-9. PubMed ID: 27466499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
